Non-Ossifying Fibroma and Fibrous Cortical Defect

Non-ossifying fibroma and fibrous cortical defect are among the most common benign bone lesions seen in children. They are usually developmental fibrous lesions rather than aggressive tumours. The distal femur, proximal tibia and distal tibia are common sites, and many are discovered incidentally after X-rays for minor trauma.

The clinical value is pattern recognition. When the radiographic appearance is classic and the child is asymptomatic, confident explanation prevents unnecessary biopsy, MRI and anxiety. The separate task is mechanical: a large lesion can thin the cortex and predispose to pathological fracture, especially in a weight-bearing bone.

The lesion consists of fibrous tissue within cortex and metaphyseal cancellous bone. It is eccentric and cortically based, usually near the metaphysis. As the child grows, the lesion appears to move away from the physis and often becomes more sclerotic before involuting.

The sclerotic rim and narrow zone of transition reflect slow, non-aggressive behaviour. The lesion becomes clinically important when it occupies enough bone diameter to reduce bending strength. Pain without fracture is not the typical story and should prompt careful clinical correlation.

Although NOF/FCD is fundamentally a radiographic diagnosis, its microscopic appearance is examinable and explains the imaging. Macroscopically the lesion is well-circumscribed, firm and characteristically yellow-brown — the colour gives the older synonym fibroxanthoma.

Histologically it is a benign fibrous (fibrohistiocytic) lesion showing:

• Bland spindle fibroblasts and myofibroblasts arranged in a whorled or storiform ("cartwheel") pattern within a collagenous stroma.
• Scattered benign multinucleated osteoclast-type giant cells.
• Foamy lipid-laden macrophages (xanthoma cells) and haemosiderin-laden macrophages — the latter give the brown colour.
• No cytological atypia and no malignant mitoses, and crucially no osteoid or bone produced by the lesion itself — a key distinction from osteosarcoma, and from fibrous dysplasia, which contains metaplastic woven bone.

The histology is identical across the size spectrum, so a fibrous cortical defect and a non-ossifying fibroma cannot be separated microscopically — they differ only in size and extent. The picture is also indistinguishable from a benign fibrous histiocytoma of bone, which is essentially a NOF arising in an atypical (older, non-metaphyseal, sometimes painful) setting. More recently, activating mutations in the MAP-kinase pathway (for example in KRAS and FGFR1) have been reported in NOF, placing it on a spectrum with other MAPK-driven benign bone lesions.

Beyond the practical spectrum above, the lesion evolves through a predictable radiographic life-cycle described by the Ritschl stages. This is the common language the natural-history and fracture-risk literature uses (the surveillance and pain studies in the Evidence Base are all framed around it), so an examiner may ask you to describe it.

The staging earns its keep in two ways. It explains why a NOF appears to "migrate" down the shaft with growth — the lesion stays put while the physis grows away from it. And it focuses fracture-risk counselling and six-to-twelve-month surveillance on the lucent stage B lesion, with discharge once a lesion sclerose into stage C–D.

View larger

History

Ask why the X-ray was taken. In many children, the lesion is incidental and the injury pain comes from a sprain or contusion rather than the lesion. Ask whether pain preceded trauma, whether pain is at rest or night, and whether the child has fever, weight loss, systemic symptoms or previous fracture through the same area.

Examination

Most incidental lesions have a normal examination. If there is pain, localise it carefully and correlate it with the X-ray. Look for swelling, deformity, tenderness, loss of function and inability to weight bear. A mass, skin change or pain out of proportion is not a typical NOF finding. If fracture is present, document alignment, adjacent joint motion and neurovascular status.

Plain radiographs in two planes are usually enough when the lesion is classic. The diagnosis should be made from the pattern: eccentric, metaphyseal, cortically based, lytic, sclerotic rim and narrow transition zone. Measure lesion size and cortical thinning when fracture risk is relevant.

View larger

MRI is not routine for classic incidental NOF. It is useful when symptoms, location or imaging features are atypical, or when the diagnosis is uncertain. Biopsy is avoided when the radiographic appearance is classic because it adds morbidity without improving care.

The eccentric metaphyseal lucency of a NOF overlaps with several lesions. The discriminators are location within the bone (cortical/eccentric versus central), zone of transition, periosteal reaction and the clinical story.

Clinical complications

• Pathological fracture in a large lesion.
• Recurrent fracture if a large lesion persists.
• Pain from an unrelated diagnosis attributed to NOF.
• Missed aggressive lesion when red flags are ignored.

Management complications

• Unnecessary biopsy, MRI or surgery.
• Excessive activity restriction and family anxiety.
• Curettage, graft or fixation complications.
• Delayed return to sport after fracture.

Non-ossifying fibroma and fibrous cortical defect management is usually about recognising a benign lesion and deciding whether fracture risk changes treatment. Most are incidental and need reassurance, but large, expansile, weight-bearing lesions or lesions associated with pain or fracture need a more formal plan.

Do not biopsy a classic asymptomatic NOF simply because it is large on a report. Conversely, do not dismiss pain, rapid growth, aggressive radiographic features or a lesion in an atypical patient. The important clinical distinction is typical benign behaviour versus diagnostic uncertainty.

Surgery is considered for symptomatic lesions, impending fracture risk, recurrent fracture, large structural lesions in high-load regions or when fixation is required for a pathological fracture. Curettage, grafting and internal fixation decisions should be based on mechanical risk and diagnosis confidence.

How to describe the X-ray

Use the exact language: eccentric metaphyseal cortically based lytic lesion with a sclerotic rim and narrow zone of transition. Then add site, size, cortical thinning and whether there is fracture.

Common pitfalls

• Calling it cancer.
• Biopsying a classic asymptomatic lesion.
• Ignoring aggressive features.
• Ignoring fracture risk in a large lesion.
• Attributing unrelated pain to the lesion.
• Forgetting to explain the benign natural history to the family.

Counselling language

Families often hear "bone lesion" and think cancer. A clear explanation helps: this is a common benign childhood lesion that often heals with growth. If it is large, the concern is bone strength rather than cancer behaviour.

Global epidemiology

• NOF/FCD are the most common benign skeletal lesions of childhood and adolescence; classic radiographic estimates suggest fibrous cortical defects are present in a substantial minority of children (figures of around 30 percent of children in some radiographic series), with most regressing spontaneously by skeletal maturity.
• Peak presentation is in the first two decades, with a slight male predominance; the distal femur, proximal tibia and distal tibia dominate, reflecting the rapidly growing metaphyses of the lower limb.
• Multifocal disease raises the possibility of Jaffe-Campanacci syndrome or neurofibromatosis type 1, which carry materially higher fracture risk.

Side-by-side guidance

The practical message is consistent worldwide: a classic asymptomatic lesion is diagnosed radiographically and observed; anything atypical is referred before biopsy. Differences are of emphasis (thresholds for follow-up imaging and prophylactic surgery), not of principle.

Registry and database notes

There is no dedicated implant registry for NOF because it is rarely implant-treated. Relevant data instead come from orthopaedic-oncology referral databases and paediatric fracture series, which consistently show that pathological fractures cluster in large lucent lower-limb lesions and that misreferral of benign lesions (and of stress fractures complicating them) as suspected sarcoma is common.

High- versus limited-resource practice

• Well-resourced settings: ready access to MRI and specialist sarcoma services allows confident non-operative management with selective imaging; the main risk is over-investigation and over-treatment of a benign lesion.
• Limited-resource settings: plain radiography remains the cornerstone, which is appropriate because classic NOF is a radiographic diagnosis; the priorities are recognising red flags that warrant referral and avoiding both unnecessary biopsy and missed aggressive lesions when advanced imaging is scarce.

Most of the debate around NOF/FCD is about how aggressively to risk-stratify and intervene, not about the benign diagnosis itself.

• Fracture-risk thresholds are imperfect. The classic Arata "greater than 50 percent transverse diameter plus over 33 mm length" rule comes from a retrospective fracture cohort with no asymptomatic comparison group, so it identifies lesions that have already fractured rather than reliably predicting who will. Many large lesions never fracture, so thresholds inform conversation rather than mandate surgery.
• Whether to follow up at all. Small classic asymptomatic lesions may be discharged without imaging, while larger lesions are often reviewed until sclerosis or ossification appears. There is no high-level evidence defining the optimal interval; six to twelve month intervals through the lucent (Ritschl B) stage are pragmatic rather than proven.
• Prophylactic curettage versus watchful waiting. Curettage and grafting reliably promotes healing but carries its own morbidity (growth-plate injury, recurrence, donor-site issues). For a lesion that may involute spontaneously, the threshold for prophylactic surgery is genuinely contested and should be individualised.
• Pain attribution. Recent cross-sectional data show spontaneous pain is reported in roughly half of children with FCD/NOF, challenging the dogma that these lesions are always painless and reminding clinicians to exclude stress reaction, stress fracture and alternative pathology before attributing pain to the lesion.
• Role of CT/MRI. Advanced imaging is reserved for atypical features or structural questions plain films cannot answer; routine cross-sectional imaging of a classic lesion adds radiation, cost and anxiety without changing management.